HEADER HYDROLASE/HYDROLASE INHIBITOR 12-SEP-11 3TS4 TITLE HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE METALLOELASTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALITIC SUBUNIT (UNP RESIDUES 106-263); COMPND 5 SYNONYM: MME, MACROPHAGE ELASTASE, ME, HME, MATRIX METALLOPROTEINASE- COMPND 6 12, MMP-12; COMPND 7 EC: 3.4.24.65; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HME, MMP12; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET24A KEYWDS PSEUDO DIPEPTIDES, POTENT INHIBITORS, METZINCIN, ZINC PROTEASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,V.DIVE,L.DEVEL,B.CZARNY,F.BEAU,L.VERA REVDAT 3 13-SEP-23 3TS4 1 REMARK SEQADV LINK REVDAT 2 17-OCT-12 3TS4 1 JRNL REVDAT 1 20-JUN-12 3TS4 0 JRNL AUTH L.DEVEL,F.BEAU,M.AMOURA,L.VERA,E.CASSAR-LAJEUNESSE,S.GARCIA, JRNL AUTH 2 B.CZARNY,E.A.STURA,V.DIVE JRNL TITL SIMPLE PSEUDO-DIPEPTIDES WITH A P2' GLUTAMATE: A NOVEL JRNL TITL 2 INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER JRNL TITL 3 METZINCINS. JRNL REF J.BIOL.CHEM. V. 287 26647 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22689580 JRNL DOI 10.1074/JBC.M112.380782 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23181 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.9828 - 3.1734 0.98 2874 152 0.1590 0.1739 REMARK 3 2 3.1734 - 2.5191 1.00 2806 148 0.1757 0.2222 REMARK 3 3 2.5191 - 2.2008 1.00 2742 144 0.1813 0.2104 REMARK 3 4 2.2008 - 1.9996 1.00 2755 146 0.1770 0.2140 REMARK 3 5 1.9996 - 1.8563 1.00 2724 143 0.1776 0.1857 REMARK 3 6 1.8563 - 1.7468 1.00 2736 143 0.1984 0.2060 REMARK 3 7 1.7468 - 1.6594 1.00 2730 144 0.2271 0.2571 REMARK 3 8 1.6594 - 1.5871 0.98 2654 140 0.2762 0.2966 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 53.45 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36540 REMARK 3 B22 (A**2) : -0.19280 REMARK 3 B33 (A**2) : -0.17260 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 1398 REMARK 3 ANGLE : 1.612 1899 REMARK 3 CHIRALITY : 0.095 188 REMARK 3 PLANARITY : 0.005 253 REMARK 3 DIHEDRAL : 18.681 482 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 7.2644 15.8920 3.0981 REMARK 3 T TENSOR REMARK 3 T11: 0.0757 T22: 0.0471 REMARK 3 T33: 0.0157 T12: 0.0174 REMARK 3 T13: 0.0131 T23: 0.0461 REMARK 3 L TENSOR REMARK 3 L11: 6.4628 L22: 1.5624 REMARK 3 L33: 1.1953 L12: 0.1740 REMARK 3 L13: 0.6073 L23: 0.0040 REMARK 3 S TENSOR REMARK 3 S11: -0.0246 S12: -0.3765 S13: -0.3007 REMARK 3 S21: 0.0770 S22: 0.0391 S23: 0.0268 REMARK 3 S31: 0.0388 S32: -0.0831 S33: -0.0129 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3TS4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067851. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99190 REMARK 200 MONOCHROMATOR : HORIZONTALLY DIFFRACTING SI REMARK 200 (111) MONOCHROMATOR AND PT REMARK 200 COATED MIRRORS IN KIRKPATRICK- REMARK 200 BAEZ GEOMETRY FOR FOCUSING REMARK 200 OPTICS : BENT CYLINDRICAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23208 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 33.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.670 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.58 REMARK 200 R MERGE FOR SHELL (I) : 0.63200 REMARK 200 R SYM FOR SHELL (I) : 0.80500 REMARK 200 FOR SHELL : 2.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3LIK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MMP12 AT 0.4 MM CO-CRYSTALLIZATION, REMARK 280 WITH 100MM AHA AND NON-CHELATING INHIBITOR EEG AT 1.1 MM WITH REMARK 280 RESERVOIR: 27% PEG 10K, 0.1M GLYCINE. AHA REMOVED DURING CRYO- REMARK 280 SOAK FOR 5 MIN IN 30% MPEG2K, 10% ETHYLENE GLYCOL, 200 MM REMARK 280 IMIDAZOLE MALATE, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K, PH 9.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.04500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.82500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.04500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.82500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 242 CD1 TYR A 242 CE1 -0.106 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 110 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 110 38.07 -94.19 REMARK 500 HIS A 206 -149.42 -145.21 REMARK 500 HIS A 206 -139.71 -150.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 304 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 124 OD2 REMARK 620 2 ASP A 124 OD1 50.6 REMARK 620 3 GLU A 199 O 137.8 163.5 REMARK 620 4 GLU A 199 OE2 86.8 87.3 79.9 REMARK 620 5 GLU A 201 O 75.8 120.2 75.4 117.3 REMARK 620 6 HOH A 422 O 97.6 87.3 103.4 168.3 74.3 REMARK 620 7 HOH A 434 O 137.7 87.4 81.6 86.8 142.3 82.7 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 158 O REMARK 620 2 GLY A 190 O 164.9 REMARK 620 3 GLY A 192 O 92.0 95.4 REMARK 620 4 ASP A 194 OD2 94.0 99.3 89.7 REMARK 620 5 HOH A 414 O 87.1 84.3 174.1 96.2 REMARK 620 6 HOH A 421 O 77.7 90.2 82.1 168.1 92.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 168 NE2 REMARK 620 2 ASP A 170 OD2 112.9 REMARK 620 3 HIS A 183 NE2 112.0 113.4 REMARK 620 4 HIS A 196 ND1 107.8 96.7 113.1 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 305 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 175 OD2 REMARK 620 2 GLY A 176 O 90.3 REMARK 620 3 GLY A 178 O 85.8 83.0 REMARK 620 4 ILE A 180 O 94.1 175.5 96.7 REMARK 620 5 ASP A 198 OD1 93.9 88.8 171.8 91.6 REMARK 620 6 GLU A 201 OE2 171.1 87.2 85.4 88.3 94.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 218 NE2 REMARK 620 2 HIS A 222 NE2 102.2 REMARK 620 3 HIS A 228 NE2 110.6 103.5 REMARK 620 4 EEG A 306 O4E 129.0 114.9 93.9 REMARK 620 5 EEG A 306 O4 90.7 93.6 148.7 54.9 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-{3-[4-(4-PHENYLTHIOPHEN-2-YL)PHENYL]PROPANOYL}-L- REMARK 630 ALPHA-GLUTAMYL-L-ALPHA-GLUTAMYL-AMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 EEG A 306 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 03J GLU GLU NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEG A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 308 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LIK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIL RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIR RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LJG RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3TSK RELATED DB: PDB REMARK 900 RELATED ID: 3TT4 RELATED DB: PDB REMARK 900 RELATED ID: 3TVC RELATED DB: PDB DBREF 3TS4 A 106 263 UNP P39900 MMP12_HUMAN 106 263 SEQADV 3TS4 MET A 105 UNP P39900 INITIATING METHIONINE SEQADV 3TS4 ASP A 171 UNP P39900 PHE 171 ENGINEERED MUTATION SEQRES 1 A 159 MET GLY PRO VAL TRP ARG LYS HIS TYR ILE THR TYR ARG SEQRES 2 A 159 ILE ASN ASN TYR THR PRO ASP MET ASN ARG GLU ASP VAL SEQRES 3 A 159 ASP TYR ALA ILE ARG LYS ALA PHE GLN VAL TRP SER ASN SEQRES 4 A 159 VAL THR PRO LEU LYS PHE SER LYS ILE ASN THR GLY MET SEQRES 5 A 159 ALA ASP ILE LEU VAL VAL PHE ALA ARG GLY ALA HIS GLY SEQRES 6 A 159 ASP ASP HIS ALA PHE ASP GLY LYS GLY GLY ILE LEU ALA SEQRES 7 A 159 HIS ALA PHE GLY PRO GLY SER GLY ILE GLY GLY ASP ALA SEQRES 8 A 159 HIS PHE ASP GLU ASP GLU PHE TRP THR THR HIS SER GLY SEQRES 9 A 159 GLY THR ASN LEU PHE LEU THR ALA VAL HIS GLU ILE GLY SEQRES 10 A 159 HIS SER LEU GLY LEU GLY HIS SER SER ASP PRO LYS ALA SEQRES 11 A 159 VAL MET PHE PRO THR TYR LYS TYR VAL ASP ILE ASN THR SEQRES 12 A 159 PHE ARG LEU SER ALA ASP ASP ILE ARG GLY ILE GLN SER SEQRES 13 A 159 LEU TYR GLY HET ZN A 301 1 HET ZN A 302 1 HET CA A 303 1 HET CA A 304 1 HET CA A 305 1 HET EEG A 306 40 HET IMD A 307 5 HET GOL A 308 6 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM EEG N-{3-[4-(4-PHENYLTHIOPHEN-2-YL)PHENYL]PROPANOYL}-L- HETNAM 2 EEG ALPHA-GLUTAMYL-L-ALPHA-GLUTAMYL-AMIDE HETNAM IMD IMIDAZOLE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CA 3(CA 2+) FORMUL 7 EEG C29 H31 N3 O7 S FORMUL 8 IMD C3 H5 N2 1+ FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *213(H2 O) HELIX 1 1 ASN A 126 ASN A 143 1 18 HELIX 2 2 LEU A 212 LEU A 224 1 13 HELIX 3 3 SER A 251 TYR A 262 1 12 SHEET 1 A 5 LYS A 148 LYS A 151 0 SHEET 2 A 5 TYR A 113 ILE A 118 1 N ILE A 114 O LYS A 148 SHEET 3 A 5 ILE A 159 ALA A 164 1 O VAL A 161 N ARG A 117 SHEET 4 A 5 ALA A 195 ASP A 198 1 O PHE A 197 N VAL A 162 SHEET 5 A 5 ALA A 182 ALA A 184 -1 N HIS A 183 O HIS A 196 SHEET 1 B 2 TRP A 203 THR A 204 0 SHEET 2 B 2 THR A 210 ASN A 211 1 O THR A 210 N THR A 204 LINK OD2 ASP A 124 CA CA A 304 1555 1555 2.47 LINK OD1 ASP A 124 CA CA A 304 1555 1555 2.70 LINK O ASP A 158 CA CA A 303 1555 1555 2.40 LINK NE2 HIS A 168 ZN ZN A 302 1555 1555 2.10 LINK OD2 ASP A 170 ZN ZN A 302 1555 1555 1.96 LINK OD2 ASP A 175 CA CA A 305 1555 1555 2.44 LINK O GLY A 176 CA CA A 305 1555 1555 2.32 LINK O GLY A 178 CA CA A 305 1555 1555 2.39 LINK O ILE A 180 CA CA A 305 1555 1555 2.34 LINK NE2 HIS A 183 ZN ZN A 302 1555 1555 2.11 LINK O GLY A 190 CA CA A 303 1555 1555 2.37 LINK O GLY A 192 CA CA A 303 1555 1555 2.36 LINK OD2 ASP A 194 CA CA A 303 1555 1555 2.50 LINK ND1 HIS A 196 ZN ZN A 302 1555 1555 2.00 LINK OD1 ASP A 198 CA CA A 305 1555 1555 2.38 LINK O GLU A 199 CA CA A 304 1555 1555 2.38 LINK OE2 GLU A 199 CA CA A 304 1555 1555 2.56 LINK O GLU A 201 CA CA A 304 1555 1555 2.51 LINK OE2 GLU A 201 CA CA A 305 1555 1555 2.38 LINK NE2 HIS A 218 ZN ZN A 301 1555 1555 2.08 LINK NE2 HIS A 222 ZN ZN A 301 1555 1555 2.07 LINK NE2 HIS A 228 ZN ZN A 301 1555 1555 2.05 LINK ZN ZN A 301 O4E EEG A 306 1555 1555 2.11 LINK ZN ZN A 301 O4 EEG A 306 1555 1555 2.49 LINK CA CA A 303 O HOH A 414 1555 1555 2.40 LINK CA CA A 303 O HOH A 421 1555 1555 2.52 LINK CA CA A 304 O HOH A 422 1555 1555 2.60 LINK CA CA A 304 O HOH A 434 1555 1555 2.47 SITE 1 AC1 4 HIS A 218 HIS A 222 HIS A 228 EEG A 306 SITE 1 AC2 4 HIS A 168 ASP A 170 HIS A 183 HIS A 196 SITE 1 AC3 6 ASP A 158 GLY A 190 GLY A 192 ASP A 194 SITE 2 AC3 6 HOH A 414 HOH A 421 SITE 1 AC4 5 ASP A 124 GLU A 199 GLU A 201 HOH A 422 SITE 2 AC4 5 HOH A 434 SITE 1 AC5 6 ASP A 175 GLY A 176 GLY A 178 ILE A 180 SITE 2 AC5 6 ASP A 198 GLU A 201 SITE 1 AC6 27 THR A 154 GLY A 155 ILE A 180 LEU A 181 SITE 2 AC6 27 ALA A 182 HIS A 183 LEU A 214 HIS A 218 SITE 3 AC6 27 GLU A 219 HIS A 222 HIS A 228 SER A 230 SITE 4 AC6 27 PRO A 232 LYS A 233 ALA A 234 VAL A 235 SITE 5 AC6 27 PHE A 237 PRO A 238 THR A 239 TYR A 240 SITE 6 AC6 27 LYS A 241 ZN A 301 HOH A 469 HOH A 483 SITE 7 AC6 27 HOH A 495 HOH A 540 HOH A 570 SITE 1 AC7 3 TYR A 132 LYS A 136 ILE A 245 SITE 1 AC8 3 HIS A 172 ALA A 184 HOH A 595 CRYST1 70.090 63.650 37.370 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014267 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015711 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026759 0.00000